Compugen (CGEN) Current Assets (2009 - 2026)
Compugen (CGEN) posted quarterly Current Assets of $137.3 million for Q1 2026, up 28.43% year-over-year from $106.9 million in Q1 2025, and down 7.25% on a QoQ basis from $148.0 million in Q4 2025.
Analysis
Compugen (CGEN) Current Assets (2009 - 2026) Analysis & Trends
Compugen has reported Current Assets for 18 years, with the latest figure at $137.3 million in Q1 2026.
- Current Assets for Q1 2026 came in at $137.3 million, up 28.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $137.3 million (up 28.43% YoY), and the FY2025 annual result was $148.0 million, up 39.65% from the prior year.
- Current Assets slipped to $137.3 million in Q1 2026, from $148.0 million in the prior quarter.
- Over five years, Current Assets peaked at $148.0 million in Q4 2025 and troughed at $60.3 million in Q3 2023.
- A 5-year average of $101.1 million and a median of $102.1 million in 2024 frame the typical range for Current Assets.
- The widest annual swing landed in 2023, when Current Assets sank 33.8%; it then soared 90.52% in 2024.
- A 5-year view of Current Assets shows it stood at $86.1 million in 2022, then jumped by 33.04% to $114.6 million in 2023, then fell by 7.49% to $106.0 million in 2024, then soared by 39.65% to $148.0 million in 2025, then declined by 7.25% to $137.3 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $137.3 million in Q1 2026, $148.0 million in Q4 2025, and $88.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 5.82 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.03 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 7.22 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.76 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 | 129.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 129.41 Mn |
| Mar 31, 2026 | 137.28 Mn |
| Dec 31, 2025 | 148.02 Mn |
| Sep 30, 2025 | 88.92 Mn |
| Jun 30, 2025 | 97.64 Mn |
| Mar 31, 2025 | 106.89 Mn |
| Dec 31, 2024 | 106.00 Mn |
| Sep 30, 2024 | 114.83 Mn |
| Jun 30, 2024 | 102.13 Mn |
| Mar 31, 2024 | 105.57 Mn |
| Dec 31, 2023 | 114.58 Mn |
| Sep 30, 2023 | 60.27 Mn |
| Jun 30, 2023 | 69.40 Mn |
| Mar 31, 2023 | 76.44 Mn |
| Dec 31, 2022 | 86.13 Mn |
| Sep 30, 2022 | 91.04 Mn |
| Jun 30, 2022 | 101.98 Mn |
| Mar 31, 2022 | 112.12 Mn |
| Dec 31, 2021 | 123.22 Mn |
| Sep 30, 2021 | 112.28 Mn |